Kristin Moberg Aakre

Dr Kristin Moberg Aakre

M.D. Ph.D.

Senior Consultant, Associate Professor
Department of medical biochemistry and pharamcology, Haukeland University Hospital and Department of Clinical Science, University of Bergen
Bergen, NORWAY

Kristin Moberg Aakre is a medical doctor, board certified in laboratory medicine since 2009. She completed her PhD in 2011, focusing on clinical use of renal biomarkers. At present she is working as Senior Consultant in clinical chemistry at Haukeland University Hospital and Associate Professor at the University of Bergen.  

She has published more than 65 articles in peer-reviewed international journals and is PI of several large clinical trials focusing on diagnostic and prognostic properties of cardiac biomarkers, with a particular focus on acute coronary syndrome. She has also published within biological variation and analytical quality specifications, mainly related to cardiac biomarkers. She is interested in guideline development and education, currently being member of the IFCC Committee on Clinical Application of Cardiac Biomarkers and the EFLM Workinggrup of Cardiac Biomarkers. Since 2022 she has been Associate Editor of Clinical Biochemistry.

Fred Apple

Prof Fred S. Apple


Consultant, Division of Ischemic Heart Disease and Critical Care, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA

Fred Apple PhD DABCC is on the Medical Staff, Department of Laboratory Medicine & Pathology, at Hennepin Healthcare/Hennepin County Medical Center, in Minneapolis, where he serves as Co-Medical Director of the Clinical and Forensic Toxicology Laboratory, Principal Investigator of the CLIA certified Cardiac Biomarkers Trials Laboratory at the Hennepin Healthcare Research Institute and is a Professor of Laboratory Medicine & Pathology at the University of Minnesota. Dr. Apple’s applied research has focused in the area of cardiac biomarkers involving acute coronary syndrome, heart failure, heart injury, and most recently COVID-19; serving as PI on five clinicaltrials.gov studies. He current serves as an Associate Editor of Clinical Chemistry, a member of the ‘Universal Definition of Myocardial Infarction and Myocardial Injury’ Global Task Force, chair of the IFCC Committee on Clinical Application of Cardiac Biomarkers, and member of the AACC Academy Laboratory Medicine Practice Guidelines for Myocardial Infarction and Heart Failure. Furthermore, he is program Co-Director of the Clinical Chemistry COMACC Fellowship at Hennepin County Medical Center.

Prof Rick Body

Dr Anda Bulgara

Dr Anda Bularga

Clinical Research Fellow
BHF Centre for Cardiovascular Science
University of Edinburgh, UK

Dr Bularga is a clinical research fellow in the BHF Centre for Cardiovascular Science, University of Edinburgh. Her PhD work uses cardiovascular data to investigate the role of cardiac biomarkers in the risk stratification of patients with acute coronary syndrome and to evaluate the mechanisms of myocardial injury in type 2 myocardial infarction. Dr Bularga is due to start her cardiology registrar training in the South-East of Scotland in August 2022.

Prof Robert H Christenson


Professor of Pathology Professor of Medical and Research Technology
University of Maryland School of Medicine
Baltimore, USA

Rob Christenson is Professor of Pathology and Professor of Medical and Research Technology at the University of Maryland School of Medicine. Dr. Christenson has published over 3800 peer-reviewed papers, 6 books, 41 textbook chapters and holds 5 patents.  Dr. Christenson currently serves on his university’s Medical School Admissions Committee and on University of Maryland’s Appointment, Promotion and Tenure Committee.  Clinically, Prof. Christenson is Medical Director of the Core Laboratories and Point-of-Care Testing at the University of Maryland Medical Center. He has an active research program in the area of biomarkers of heart disease, renal disease, and point of care testing. Dr. Christenson has held a number of professional leadership positions with organizations including on the American College of Cardiology – Accreditation Management Board. Dr. Christenson has been particularly active in his ‘home’ professional association-The American Association for Clinical Chemistry where he has been a member of the Board of Directors and was elected and served as AACC’s President.  Dr. Christenson is currently the Editor-in-Chief of the Journal of Applied Laboratory Medicine and is a contributor to Medscape. Dr. Christenson has lectured widely on Biomarker and POC testing in the USA, and around the world.

Prof Paul O Collinson

Prof Paul O Collinson


Professor of Cardiovascular Biomarkers 
St Georges’ University Hospitals NHS Foundation Trust and St Georges’ University of London
Clinical Blood Sciences and Cardiology
London, UK

Paul is Professor of Cardiovascular Biomarkers at St George’s University of London and Honorary Consultant Cardiologist, Previously Consultant Chemical Pathologist at St George’s Hospital London. studied at St Catharine’s College Cambridge (Medicine and Biochemistry) and subsequently at St Thomas Hospital and the Royal Free Hospital. He was won several prizes and awards for his work on Cardiovascular Biomarkers (ran the first RCT on cardiac diagnostics) including the Hytest Award (Now IFCC award) for lifetime achievement in cardiovascular biomarkers.  Published over 300 papers and review articles, 281 abstracts and 15 book chapters. Likes SCUBA diving and photographing sharks. Especially the ones with big teeth.

Prof Ola Hammarsten

Prof Ola Hammarsten


Institute of Biomedicine
Department of Laboratory Medicine
Sahlgrenska Academy at the University of Gothenburg
Gothenburg, SWEDEN

Ola Hammarsten is professor in Clinical Chemistry at Gothenburg University and works as a chief consultant in Clinical Chemistry at the Sahlgrenska University Hospital in Sweden. Ola studies how cardiac troponin is released and cleared as well as analytical interference. His team also develops methods to measure sensitivity to cancer treatment that induces DNA damage like radiationtherapy.

Dr. Allan Jaffe

Prof Allan Jaffe

Dr. Allan Jaffe is a graduate of the University of Maryland School of Medicine. He received his house staff and Cardiology training at Washington University and continued there for 24 years rising to the rank of Professor of Medicine and Director of the Coronary Care Unit. He then moved to the State University of New York where he was Chair of the Cardiovascular Division, Associate Chair of Medicine for Academic Affairs, and Professor of Medicine.  After four years he moved to the Mayo Clinic where he is presently Professor of Medicine in the Department of Cardiovascular Medicine and Professor of Laboratory Medicine and Pathology. He is a noted authority on biomarkers of cardiac injury, inflammation, hemodynamic disturbance, and coagulation and particularly their clinical utility. He has published a large number of original manuscripts, book chapters, reviews, and sits on most of the prestigious editorial boards and guideline committees in the Cardiology and Clinical Chemistry communities.  He has been a principal for the Universal Definition of MI group. (USA)

Prof Nick Mills

Prof Nick Mills


British Heart Foundation Chair of Cardiology
The University of Edinburgh
BHF Centre for Cardiovascular Science, Edinburgh, UK

Professor Mills is the British Heart Foundation Professor of Cardiology at the University of Edinburgh and a Consultant Interventional Cardiologist at the Royal Infirmary of Edinburgh. His research group aims to use linked healthcare data to develop new approaches for the diagnosis and risk stratification of heart conditions, and to evaluate their impact on clinical outcomes in practice. He is the Chief Investigator of a series of multi-centred cluster randomised trials that use routine electronic health record data to evaluate the impact of high-sensitivity cardiac troponin testing on outcomes in patients with suspected acute coronary syndrome. 

Professor Mills is an Associate Editor at Circulation and Chair of the European Society of Cardiology Working Group on Cardiac Biomarkers. He is the Academic Lead and Senior Responsible Officer for the University of Edinburgh’s Health and Social Care Data Driven Innovation Hub. He has been a specialist member of the Diagnostics Advisory Committee for the National Institute of Health and Care Excellence (NICE) consultation on high-sensitivity troponin.

Dr Alan Reid

Scheme Organiser
UK NEQAS Cardiac Markers
Laboratory Medicine & Facilities Management Building 
Queen Elizabeth University Hospital, Glasgow, UK

Principal Clinical Scientist within the Biochemistry Department, Queen Elizabeth University Hospital, NHS Greater Glasgow & Clyde. Research interests in the use of cardiac biomarkers in acute coronary syndrome and heart failure. From 1997 developed an interest in the development of cardiac marker EQA.  I am member of European Metrology Programme for Innovation and Research (EMPIR) project: Providing the measurement infrastructure to allow quantitative diagnostic methods for biomarkers of coronary heart diseases. This EMPIR initiative was co-funded by the European Union’s Horizon 2020 research and innovation programme. This initial project has now been completed. A continuation of this project is currently being considered which will allow continued development of reference methods and material for B-type Natriuretic Peptides.

As Scheme Organiser of UK NEQAS Cardiac Marker Service continue to develop EQA schemes for both laboratory and point of care systems with current and future cardiac biomarkers. The most recent being for high sensitivity Cardiac Troponin I for point of care devices. Develop current interpretative exercises to assist in clinical interpretation of cardiac biomarker testing. 

This will be Alan’s final year as meeting organiser for Cardiac Marker Dialogues.

Dr Amy Saenger


Medical Director, Clinical Laboratories
Hennepin Healthcare/Hennepin County Medical Center
Laboratory Medicine and Pathology
Minneapolis, USA

Dr. Saenger is the Medical Director of the Clinical Laboratories, Director of Clinical Chemistry and Point-of-Care Testing at Hennepin County Medical Center and an Associate Professor of Laboratory Medicine and Pathology at the University of Minnesota. Her clinical areas of expertise are in cardiovascular biomarkers and lipids/lipoproteins, focusing on utilization and analytical aspects of cardiac troponin and natriuretic peptides. She currently serves on the IFCC Committee on Clinical Applications of Cardiac Biomarkers and the IFCC Standardization of Cardiac Troponin I Working Group. Dr. Saenger has authored over 100 peer reviewed manuscripts and book chapters, primarily related to cardiac biomarkers.

Dr Paul Welsh

Dr Paul Welsh

BHF Glasgow Cardiovascular Research Centre
University of Glasgow, UK

After completing a BSc (Hons) in Immunology, Paul completed his PhD on inflammatory markers of cardiovascular disease at University of Glasgow in 2008, and completed an MSc in Epidemiology at London School of Hygiene and Tropical Medicine with distinction, winning the 150th Anniversary prize. He has held two British Heart Foundation Research Fellowships at the BHF Glasgow Cardiovascular Research Centre, University of Glasgow. He has served on the Independent Scientific Advisory Committee for MHRA, and is an associate editor of Atherosclerosis, and Cardiovascular Research, and an editorial advisor for BMC Medicine.

Paul has a wide range of research interests encompassing biomarkers, lifestyle, and clinical research in the fields of cardiovascular disease, diabetes, metabolism, and healthy ageing, including data from clinical trials (including DiRECT, SUGAR-DM-HF, RECOVER-LV, WOSCOPS, PROSPER, ASCOT, and ADVANCE), large observational studies (such as UK Biobank, Generation Scotland, the British Regional Heart Study and MIDSPAN) and meta-analyses. He has a particular interest in cardiovascular disease risk stratification, and cardiac biomarkers. He has authored more than 200 peer-reviewed publications.

Dr Ryan Wereski

Dr Ryan Wereski

Clinical Research Fellow
University of Edinburgh
Centre for Cardiovascular Science, Edinburgh, UK

Dr Wereski is an honorary cardiology registrar in NHS Lothian and NHS Greater Glasgow and Clyde, and a Medical Research Council (MRC) clinical research fellow at the BHF Centre for Cardiovascular Science, University of Edinburgh. Ryan completed his undergraduate training at the University of St Andrews and University of Edinburgh, followed by post-graduate medical training in the West of Scotland. His research interests include the release mechanisms of cardiac troponin, as well as the clinical application of troponin testing in the acute and chronic coronary syndromes.

Scroll to top